Aida Pharmaceuticals OTC Stock Today

AIDA
 Stock
  

USD 0.0003  0.00  0.00%   

Market Performance
9 of 100
Odds Of Distress
Over 60
Aida Pharmaceuticals is trading at 3.0E-4 as of the 29th of November 2022, a No Change since the beginning of the trading day. The stock's open price was 3.0E-4. Aida Pharmaceuticals has more than 60 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Aida Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of January 2021 and ending today, the 29th of November 2022. Click here to learn more.
Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China. The company has 0 outstanding shares. More on Aida Pharmaceuticals

Moving together with Aida Pharmaceuticals

+0.73WFCWells Fargo Fiscal Year End 13th of January 2023 PairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Aida Pharmaceuticals OTC Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Aida Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Aida Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Aida Pharmaceuticals is way too risky over 90 days horizon
Aida Pharmaceuticals has some characteristics of a very speculative penny stock
Aida Pharmaceuticals appears to be risky and price may revert if volatility continues
Aida Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
The company currently holds 41.17 M in liabilities with Debt to Equity (D/E) ratio of 2.37, implying the company greatly relies on financing operations through barrowing. Aida Pharmaceuticals has a current ratio of 0.72, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Aida Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Aida Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aida Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aida Pharmaceuticals to invest in growth at high rates of return. When we think about Aida Pharmaceuticals' use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 40.51 M. Net Loss for the year was (2.18 M) with profit before overhead, payroll, taxes, and interest of 14.64 M.
ChairmanBiao Jin
Thematic IdeaDrugs (view all)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Aida Pharmaceuticals' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellOvervalued
Aida Pharmaceuticals [AIDA] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with current market capitalization of 25.11 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aida Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Aida Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Aida Pharmaceuticals conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 0 outstanding shares. Aida Pharmaceuticals currently holds about 8.28 M in cash with 7.49 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Aida Pharmaceuticals Probability Of Bankruptcy

Aida Pharmaceuticals Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Aida Pharmaceuticals market risk premium is the additional return an investor will receive from holding Aida Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Aida Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Aida Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Aida Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.

Aida Pharmaceuticals Stock Against Markets

Picking the right benchmark for Aida Pharmaceuticals otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Aida Pharmaceuticals otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Aida Pharmaceuticals is critical whether you are bullish or bearish towards Aida Pharmaceuticals at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Aida Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

Aida Pharmaceuticals Corporate Executives

Elected by the shareholders, the Aida Pharmaceuticals' board of directors comprises two types of representatives: Aida Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aida Pharmaceuticals. The board's role is to monitor Aida Pharmaceuticals' management team and ensure that shareholders' interests are well served. Aida Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aida Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.

Invested in Aida Pharmaceuticals?

The danger of trading Aida Pharmaceuticals is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aida Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aida Pharmaceuticals. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aida Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. Note that the Aida Pharmaceuticals information on this page should be used as a complementary analysis to other Aida Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Aida Pharmaceuticals OTC Stock analysis

When running Aida Pharmaceuticals price analysis, check to measure Aida Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aida Pharmaceuticals is operating at the current time. Most of Aida Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aida Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aida Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aida Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Please note, there is a significant difference between Aida Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Aida Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aida Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.